BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Characterisation of BCR-ABL1 and its constitutive tyrosine kinase activity has facilitated understanding of the pathogenesis and therapy of chronic myeloid leukaemia (CML) [1].